Impact of the cancer risk intake system on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy

Celette Sugg Skinner, Susan M. Rawl, Barry K. Moser, Adam H. Buchanan, Linda L. Scott, Victoria L. Champion, Joellen M. Schildkraut, Giovanni Parmigiani, Shelly Clark, David F. Lobach, Lori A. Bastian

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The Cancer Risk Intake System (CRIS), a computerized program that "matches" objective cancer risks to appropriate risk management recommendations, was designed to facilitate patient-clinician discussion. We evaluated CRIS in primary care settings via a single-group, self-report, pretest-posttest design. Participants completed baseline telephone surveys, used CRIS during clinic visits, and completed follow-up surveys 1 to 2 months postvisit. Compared with proportions reporting having had discussions at baseline, significantly greater proportions of participants reported having discussed tamoxifen, genetic counseling, and colonoscopy, as appropriate, after using CRIS. Most (79%) reported CRIS had "caused" their discussion. CRIS is an easily used, disseminable program that showed promising results in primary care settings.

Original languageEnglish (US)
Pages (from-to)360-365
Number of pages6
JournalJournal of general internal medicine
Volume20
Issue number4
DOIs
StatePublished - Apr 1 2005

Fingerprint

Genetic Counseling
Tamoxifen
Colonoscopy
Neoplasms
Primary Health Care
Risk Management
Ambulatory Care
Telephone
Self Report

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Impact of the cancer risk intake system on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy. / Skinner, Celette Sugg; Rawl, Susan M.; Moser, Barry K.; Buchanan, Adam H.; Scott, Linda L.; Champion, Victoria L.; Schildkraut, Joellen M.; Parmigiani, Giovanni; Clark, Shelly; Lobach, David F.; Bastian, Lori A.

In: Journal of general internal medicine, Vol. 20, No. 4, 01.04.2005, p. 360-365.

Research output: Contribution to journalArticle

Skinner, CS, Rawl, SM, Moser, BK, Buchanan, AH, Scott, LL, Champion, VL, Schildkraut, JM, Parmigiani, G, Clark, S, Lobach, DF & Bastian, LA 2005, 'Impact of the cancer risk intake system on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy', Journal of general internal medicine, vol. 20, no. 4, pp. 360-365. https://doi.org/10.1111/j.1525-1497.2005.40115.x
Skinner, Celette Sugg ; Rawl, Susan M. ; Moser, Barry K. ; Buchanan, Adam H. ; Scott, Linda L. ; Champion, Victoria L. ; Schildkraut, Joellen M. ; Parmigiani, Giovanni ; Clark, Shelly ; Lobach, David F. ; Bastian, Lori A. / Impact of the cancer risk intake system on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy. In: Journal of general internal medicine. 2005 ; Vol. 20, No. 4. pp. 360-365.
@article{c43506ba426e4365969ad0fe1c285cbe,
title = "Impact of the cancer risk intake system on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy",
abstract = "The Cancer Risk Intake System (CRIS), a computerized program that {"}matches{"} objective cancer risks to appropriate risk management recommendations, was designed to facilitate patient-clinician discussion. We evaluated CRIS in primary care settings via a single-group, self-report, pretest-posttest design. Participants completed baseline telephone surveys, used CRIS during clinic visits, and completed follow-up surveys 1 to 2 months postvisit. Compared with proportions reporting having had discussions at baseline, significantly greater proportions of participants reported having discussed tamoxifen, genetic counseling, and colonoscopy, as appropriate, after using CRIS. Most (79{\%}) reported CRIS had {"}caused{"} their discussion. CRIS is an easily used, disseminable program that showed promising results in primary care settings.",
author = "Skinner, {Celette Sugg} and Rawl, {Susan M.} and Moser, {Barry K.} and Buchanan, {Adam H.} and Scott, {Linda L.} and Champion, {Victoria L.} and Schildkraut, {Joellen M.} and Giovanni Parmigiani and Shelly Clark and Lobach, {David F.} and Bastian, {Lori A.}",
year = "2005",
month = "4",
day = "1",
doi = "10.1111/j.1525-1497.2005.40115.x",
language = "English (US)",
volume = "20",
pages = "360--365",
journal = "Journal of General Internal Medicine",
issn = "0884-8734",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Impact of the cancer risk intake system on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy

AU - Skinner, Celette Sugg

AU - Rawl, Susan M.

AU - Moser, Barry K.

AU - Buchanan, Adam H.

AU - Scott, Linda L.

AU - Champion, Victoria L.

AU - Schildkraut, Joellen M.

AU - Parmigiani, Giovanni

AU - Clark, Shelly

AU - Lobach, David F.

AU - Bastian, Lori A.

PY - 2005/4/1

Y1 - 2005/4/1

N2 - The Cancer Risk Intake System (CRIS), a computerized program that "matches" objective cancer risks to appropriate risk management recommendations, was designed to facilitate patient-clinician discussion. We evaluated CRIS in primary care settings via a single-group, self-report, pretest-posttest design. Participants completed baseline telephone surveys, used CRIS during clinic visits, and completed follow-up surveys 1 to 2 months postvisit. Compared with proportions reporting having had discussions at baseline, significantly greater proportions of participants reported having discussed tamoxifen, genetic counseling, and colonoscopy, as appropriate, after using CRIS. Most (79%) reported CRIS had "caused" their discussion. CRIS is an easily used, disseminable program that showed promising results in primary care settings.

AB - The Cancer Risk Intake System (CRIS), a computerized program that "matches" objective cancer risks to appropriate risk management recommendations, was designed to facilitate patient-clinician discussion. We evaluated CRIS in primary care settings via a single-group, self-report, pretest-posttest design. Participants completed baseline telephone surveys, used CRIS during clinic visits, and completed follow-up surveys 1 to 2 months postvisit. Compared with proportions reporting having had discussions at baseline, significantly greater proportions of participants reported having discussed tamoxifen, genetic counseling, and colonoscopy, as appropriate, after using CRIS. Most (79%) reported CRIS had "caused" their discussion. CRIS is an easily used, disseminable program that showed promising results in primary care settings.

UR - http://www.scopus.com/inward/record.url?scp=18144390845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18144390845&partnerID=8YFLogxK

U2 - 10.1111/j.1525-1497.2005.40115.x

DO - 10.1111/j.1525-1497.2005.40115.x

M3 - Article

C2 - 15857495

AN - SCOPUS:18144390845

VL - 20

SP - 360

EP - 365

JO - Journal of General Internal Medicine

JF - Journal of General Internal Medicine

SN - 0884-8734

IS - 4

ER -